Bluejay Diagnostics Inc.

NASDAQ: BJDX · Real-Time Price · USD
1.36
0.05 (3.82%)
At close: Aug 15, 2025, 3:58 PM
1.34
-1.83%
After-hours: Aug 15, 2025, 05:30 PM EDT

Bluejay Diagnostics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
4.3M 2.21M 10.11M 19.05M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
35.26K 28.66K 30.75K 16.4K
Receivables
14.56K 41.27K n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
-14.56K 223.81K n/a n/a
Total Current Assets
4.9M 3.22M 11.79M 20.66M
Property-Plant & Equipment
1.72M 1.62M 1.7M 337.37K
Goodwill & Intangibles
n/a n/a 4.46K 4.62K
Total Long-Term Assets
1.76M 1.65M 1.73M 358.38K
Total Assets
6.66M 4.87M 13.52M 21.02M
Account Payables
145.12K 491.47K 635.82K 295.78K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
113.26K n/a n/a n/a
Other Current Liabilities
4.81K 4.81K 4.81K n/a
Total Current Liabilities
810.37K 1.77M 1.64M 637.16K
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
8.57K 12.32K 15.82K n/a
Total Long-Term Liabilities
117.56K 202.31K 339.74K n/a
Total Liabilities
927.92K 1.97M 1.98M 637.16K
Total Debt
222.25K 352.98K 492.62K n/a
Common Stock
55.00 124.00 2.02K 2.01K
Retained Earnings
-34.67M -26.95M -17M -7.69M
Comprehensive Income
n/a n/a n/a -21.02M
Shareholders Equity
5.73M 2.89M 11.54M 20.38M
Total Investments
n/a n/a n/a n/a